Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma

Clinical Orthopaedics and Related Research

Volumn 376, Issue , 2000, Pages 291-303

  Scully, Sean P ^a   Berend, Keith R ^a   Toth, Alison ^a   Qi, Wen Ning ^a   Qi, Zhou ^a   Block, Joel A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; ANTINEOPLASTIC AGENT; INTERSTITIAL COLLAGENASE; MESSENGER RNA; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CHONDROSARCOMA; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; AWARDS AND PRIZES; BONE TUMOR; CELL CULTURE; CELL DIVISION; METABOLISM; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; AWARDS AND PRIZES; BONE NEOPLASMS; CELL DIVISION; CHONDROSARCOMA; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 1; NEOPLASM INVASIVENESS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED;

EID: 0034218946     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200007000-00038     Document Type: Article

References (69)

1. Alessandro R, Kohn EC: Molecular genetics of cancer. Tumor invasion and angiogenesis. Cancer 76:1874-1877, 1995.
2. Alessandro R, Minafra S, Pucci-Minafra I, et al: Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer 55:250-255, 1993.
3. Alessandro R, Spoonster J, Wersto RP, Kohn EC: Signal transduction as a therapeutic target. Curr Top Microbiol Immunol 213:167-188, 1996.
4. Barletta E, Mugnai G, Ruggieri S: Inverse relationship between invasiveness and differentiative capacity in different human neuroblastoma cell lines. Int J Cancer 70:556-560, 1997.
5. Berend KR, Toth AP, Harrelson JM, et al: Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg 80A:11-17, 1998.
6. Block JA, Inerot SE, Gitelis S, Kimura JH: The effects of long term monolayer culture on the proteoglycan phenotype of a clonal population of mature human malignant chondrocytes. Connect Tissue Res 26:295-313, 1991.
7. Block JA, Inerot SE, Gitelis S, Kimura JH: Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term cell culture [published erratum appears in J Bone Joint Surg 73A:1274, 1991]. J Bone Joint Surg 73A:647-658, 1991.
8. Block JA, Inerot SE, Kimura JH: Heterogeneity of keratan sulfate substituted on human chondrocytic large proteoglycans. J Biol Chem 267:7245-7252, 1992.
9. Block JA: A series of human chondrocyte cell lines expressing varying degrees of the differentiated phenotype. Trans Orthop Res Soc 20:468, 1995.
10. Calabro A, Hascall VC: Differential effects of brefeldin A on chondroitin sulfate and hyaluronan synthesis in rat chondrosarcoma cells. J Biol Chem 269:22764-22770, 1994.
11. Calabro A, Hascall VC, Caterson B: Monoclonal antibodies directed against epitopes within the core protein structure of the large aggregating proteoglycan (aggrecan) from the swarm rat chondrosarcoma. Arch Biochem Biophys 298:349-360, 1992.
12. Chambers A: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270, 1997.
13. Crim JR, Seeger LL: Diagnosis of low-grade chondrosarcoma. Radiology 189:503-504, 1993.
14. De Clerck YA, Shimada H, Taylor SM, Langley KE: Matrix metalloproteinases and their inhibitors in tumor progression. Ann NY Acad Sci 732:222-232, 1994.
15. DeClerck YA, Imren S: Protease inhibitors: Role and potential therapeutic use in human cancer. Eur J Cancer 30A:2170-2180, 1994.
16. DeClerck YA, Imren S, Montgomery AM, et al: Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol 425:89-97, 1997.
17. DeClerck YA, Perez N, Shimada H, et al: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708, 1992.
18. Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A: Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 17:3201-3210, 1997.
19. Frassica F: Dedifferentiated chondrosarcoma. J Bone Joint Surg 68A:1197-1205, 1986.
20. Furcht LT, Skubitz AP, Fields GB: Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab Invest 70:781-783, 1994.
21. Hasegawa T, Seki K, Yang P, et al: Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol 26:838-845, 1995.
22. Hauselmann HJ, Masuda K, Hunziker EB, et al: Adult human chondrocytes cultured in alginate form a matrix similar to native human articular cartilage. Am J Physiol Cell Physiol 40:C742-C752, 1996.
23. Helio H. Karaharju E, Bohling T, et al: Chondrosarcoma of bone. A clinical and DNA flow cytometric study. Eur J Surg Oncol 21:408-413, 1995.
24. Imren S, Kohn DB, Shimada H, et al: Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 56:2891-2895, 1996.
25. Ishiguro N, Ito T, Kurokouchi K, et al: mRNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in interface tissue around implants in loosening total hip arthroplasty. J Biomed Mater Res 32:611-617, 1996.
26. Jagasia AA, Block JA, Diaz MO, et al: Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Lett 105:77-90, 1996.
27. Jagasia AA, Block JA, Qureshi A, et al: Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Lett 105:91-103, 1996.
28. Kawashima A, Okada Y, Nakanishi I, et al: Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen Diagn Pathol 142:129-137, 1997.
29. Kawashima A, Ueda Y, Tsuchiya H, et al: Immunohistochemical localization of collagenous proteins in cartilaginous tumors: Characteristic distribution of type IX collagen. J Cancer Res Clin Oncol 120:35-40, 1993.
30. Kohn EC, Liotta LA: Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55:1856-1862, 1995.
31. Le Marer N, Bruyneel E: Comparison of in vitro invasiveness of human breast carcinoma in early or late stage with their malignancy in vivo. Anticancer Res 16:2767-2772, 1996.
32. Lewis MM, Sissons HA, Norman A, Greenspan A: Benign and malignant cartilage tumors. Instr Course Lect 36:87-114, 1987.
33. Mankin HJ, Cantley KP, Lippiello L, et al: The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses. J Bone Joint Surg 62A:160-176, 1980.
34. Mankin HJ, Cantley KP, Schiller AL, Lippiello L: The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors. J Bone Joint Surg 62A: 176-188, 1980.
35. Matrisian L: Metalloproteinases and their inhibitors in matrix remodeling. TIG 6:121-125, 1990.
36. Matrisian LM: Matrix metalloproteinase gene expression. Ann N Y Acad Sci 732:42-50, 1994.
37. McDonnell S, Fingleton B: Role of matrix metalloproteinases in invasion and metastasis: Biology, diagnosis and inhibitors. Cytotechnology 12:367-384, 1993.
38. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195, 1993.
39. Miller DR, Mankin HJ: A comparison of collagen synthesis by different categories of human chondrosarcoma in organ culture. Clin Orthop 252-257, 1982.
40. Miyake H, Hara I, Yoshimura K, et al: Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 56:2440-2445, 1996.
41. Moses MA, Shing Y: Production of matrix metalloproteinases and a metalloproteinase inhibitor by swarm rat chondrosarcoma. Biochem Biophys Res Commun 199:418-424, 1994.
42. Muller-Pillasch F, Gress TM, Yamaguchi H, et al: The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis. Pancreas 15:168-175, 1997.
43. Murphy G: Matrix metalloproteinases and their inhibitors. Acta Orthop Scand 266(Suppl):55-60, 1995.
44. Murphy G, Docherty AJ: The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120-125, 1992.
45. Murphy G, Willenbrock F, Crabbe T, et al: Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 732:31-41, 1994.
46. Nie D, Ishikawa Y, Yoshimori T, et al: Retinoic acid treatment elevates matrix metalloproteinase-2 protein and mRNA levels in avian growth plate chondrocyte cultures. J Cell Biochem 68:90-99, 1998.
47. Nuovo GJ, MacConnell PB, Simsir A, et al. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55:267-275, 1995.
48. Ohsako T, Takao S, Uemura K, et al. The invasion-MTT assay as a predictor of liver metastasis using human gastrointestinal carcinomas transplanted in nude mice. Surg Today 27:638-644, 1997.
49. Onisto M, Garbisa S, Caenazzo C, et al: Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn Mol Pathol 2:74-80, 1993.
50. Overall CM: Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann NY Acad Sci 732:51-64, 1994.
51. Overall CM: Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: Comparison with transforming growth factor-beta 1. J Cell Physiol 164:17-25, 1995.
52. Oxford JT, Doege KJ, Horton Jr WE, Morris NP: Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression. Exp Cell Res 213:28-36, 1994.
53. Ozaki T, Hillmann A, Lindner N, Blasius S, Winkelman W: Metastasis of chondrosarcoma. J Cancer Res Clin Oncol 122:625-628, 1996.
54. Ozaki T, Lindner N, Hillmann A, et al: Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 77:1292-1297, 1996.
55. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJC: Matrix metalloproteinases [Review]. Br J Surg 84:160-166, 1997.
56. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062-2072, 1994.
57. Schoedel KE, Ohori NP, Greco A, Steiner GC: Expression of metalloproteinases and tissue inhibitor in cartilaginous neoplasms of bone. Appl Immunohistochemistry 5:111-116, 1997.
58. Scully S: Prognostic markers in chondrosarcoma: Evaluation of cell proliferation and regulators of the cell cycle. Sarcoma 1:79-87, 1997.
59. Sehgal I, Baley PA, Thompson TC: Transforming growth factor beta 1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res 56:3359-3365, 1996.
60. Sheth DS, Yasko AW, Johnson ME, et al: Chondrosarcoma of the prognostic factors for 67 patients treated with definitive surgery. Cancer 78:745-750, 1996.
61. Shimizu S, Nishikawa Y, Kuroda K, et al: Involvement of transforming growth factor beta 1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 56:3366-3370, 1996.
62. Siebert PD, Larrick JW: PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 14:244-249, 1993.
63. Sieuwerts AM, Klijn JG, Foekens JA: Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: Influences of the ability of cells to migrate through the filter membrane. Clin Exp Metastasis 15:53-62, 1997.
64. Springfield DS, Gebhardt MC, McGuire MH: Chondrosarcoma: A review. Instr Course Lect 45:417-424, 1996.
65. Stetler-Stevenson WG: Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14:259-268, 1994.
66. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573, 1993.
67. Strohmaier AR, Spring H, Spiess E: Three-dimensional analysis of the substrate-dependent invasive behavior of a human lung tumor cell line with a confocal laser scanning microscope. Histochem Cell Biol 105:179-185, 1996.
68. Ueda Y, Oda Y, Tsuchiya H, Tomita K, Nakanishi I: Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Arch A Pathol Anat Histopathol 417:291-297, 1990.
69. Woessner Jr JF: The family of matrix metalloproteinases. Ann N Y Acad Sci 732:11-21, 1994.